Morepen Laboratories peers

Companies like Morepen Laboratorieslatest year

Market cap and P/E at the last close; sales growth is the latest quarter on the same quarter a year before; ROE for the latest financial year.

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

MOREPENLAB₹125.58

Morepen Laboratories Limited

· Pharma & Health
₹ CrorePeersIOLCPINNOVACAPFDCORCHPHARMASENORESSANOFIGUJTHEMRPGLIFEMcap ₹6,881 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
MOREPENLAB
FY26
IOLCP
FY26
INNOVACAP
FY26
FDC
FY26
Peer
Average
Valuation — at last close
P/E72.59×38.51×41.95×◆ 21.78×34.08× +113%
P/B5.52×2.95×5.55×◆ 2.47×3.66× +51%
EV/EBITDA55.60×19.45×25.96×◆ 16.20×20.54× +171%
Market Cap₹6,881 Cr₹5,302 Cr₹6,007 Cr₹6,131 Cr₹5,813 Cr +18%
Growth
Revenue CAGR 3Y◆ 8.40%1.51%—6.77%4.14% +103%
Revenue CAGR 5Y8.73%——◆ 10.24%10.24% -15%
Net Income CAGR 3Y◆ 34.87%-0.36%—13.23%6.44% +442%
Revenue YoY (latest Q)◆ 81.38%37.08%33.94%20.95%30.66% +165%
Net Income YoY (latest Q)◆ 117.48%89.80%42.27%72.92%68.33% +72%
Profitability
EBITDA Margin6.96%11.60%14.90%◆ 15.94%14.15% -51%
Net Income Margin5.25%5.94%8.78%◆ 12.96%9.23% -43%
Return on Common Equity7.90%7.90%◆ 14.03%11.81%11.25% -30%
Return on Capital Employed6.55%10.29%◆ 15.38%11.69%12.45% -47%
Return on Assets5.11%5.54%8.38%◆ 9.99%7.97% -36%
Credit & Quality
Total Debt/Equity0.16×0.07×0.32×◆ 0.00×0.13× +23%
Interest Coverage5.43×12.97×11.70×◆ 57.54×27.40× -80%
Scale — latest FY
Revenue / Total Income₹1,806 Cr₹2,319 Cr₹1,630 Cr₹2,171 Cr₹2,040 Cr -11%
Net Income₹94.9 Cr₹138 Cr₹143 Cr₹281 Cr₹187 Cr -49%
Total Assets₹1,936 Cr₹2,587 Cr₹1,838 Cr₹2,919 Cr₹2,448 Cr -21%
EPS₹1.73₹4.69₹25.02₹17.29₹15.67 -89%
Book Value per Share₹22.75₹61.27₹188.99₹152.64₹134.3 -83%
◆ best value in the comp set per metric · Δ = subject vs average of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.